Physician
Conway, Stephen
Conway, Stephen was paid $2.20M by Medicaid between Jan 2018 and Mar 2023, across 38 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 23% of everything it billed.
33Billing provider infoCONWAY, STEPHEN
LOWELL, MA 01852
LOWELL, MA 01852
33aNPI1194762120assigned 05/31/2006
33bProvider typePediatrics Physician
28Total paid$2.20M
24GClaims57,242
24DCodes billed38
24AFirst – last monthJan 2018 – Mar 2023
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#19 of 1,273
Median peer was paid$24K
This provider vs. median92×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,105 | $419K | |
| 2019 | 12,274 | $433K | |
| 2020 | 9,325 | $334K | |
| 2021 | 9,953 | $364K | |
| 2022 | 12,054 | $501K | |
| 2023 | 3,531 | $149K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 9,020 | 8,633 | $515K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 4,627 | 4,389 | $434K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 9.3% | 4,660 | 4,635 | $204K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.2% | 1,941 | 1,940 | $158K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.4% | 1,709 | 1,709 | $141K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.4% | 1,113 | 1,113 | $98K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.2% | 1,189 | 1,177 | $92K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.8% | 1,629 | 1,601 | $83K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.3% | 878 | 865 | $72K |
| 90461 | 2.7% | 1,565 | 1,557 | $60K | |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 2.5% | 6,181 | 6,164 | $56K |
| 92558 | 2.0% | 1,781 | 1,780 | $44K |
26 more codes
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.5% | 3,280 | $34K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.4% | 999 | $31K |
| 96127 | 1.3% | 2,736 | $28K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.0% | 1,660 | $22K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 919 | $22K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,584 | $21K |
| 99173 | <1% | 870 | $15K | |
| 99177 | <1% | 1,049 | $14K | |
| 83655 | <1% | 876 | $10K | |
| 87081 | <1% | 1,256 | $10K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,147 | $9K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 442 | $7K |
| 94760 | <1% | 3,036 | $7K | |
| 36416 | <1% | 563 | $5K | |
| 87634 | <1% | 44 | $3K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 44 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 44 | $1K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 13 | $1K |
| 99188 | <1% | 36 | $936.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 54 | $839.30 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 15 | $515.25 |
| 81003 | <1% | 198 | $385.55 | |
| 87807 | <1% | 16 | $175.91 | |
| 92551 | <1% | 12 | $119.16 | |
| 96161 | <1% | 12 | $46.32 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 44 | $13.20 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.